Home
My Account
About Us
Forum
Contact us
الواجهة العربية
epharmaweb.com
Medical News Medical News
Aricles Articles
Events Events
Guidelines Guidelines
Videos Library Videos Library
Diseases Diseases
Follow us : facebook twitter Digg Linkedin Boxiz
Newsletter

Please select the categories you are intersted in:
News Articles Guidelines Events Videos Journals' abstracts

Latest Subscribers
Advanced Search »

Cebrotonin

Main

You must sign in to use this servcie


Feedback - Please use the form below to send your query or comment

You must sign in to use this servcie

Username:
Password:

Info

Indications:

Treatment of the elderly w/ some degree of cerebral functional impairment such as loss of memory, lack of conc or alertness, mood changes, vertigo, personal negligence & deterioration in behaviour. Treatment of symptoms related to chronic alcoholism w/drawal & of chronic alcoholic patients suffering from a psycho organic brain syndrome. Treatment of coma of vascular, traumatic or toxic origin, as well as cognitive deficit &/or vertigo resulting from head injury. Patients suffering from myoclonus of cortical origin, (used in combination w/ other anti-myoclonic therapies).

Contraindications:

Cerebral haemorrhage, end stage renal disease.

Adverse reactions:

The side effects reported in connection with THIS MEDICINE include nervousness, agitation, irritability, anxiety and sleep disturbances. The incidence of these during clinical trials was ≤5% and they were more often noted in the older patients taking >2.4 g daily. In the majority of cases, a dose reduction sufficed to make these symptoms disappear. Some patients may complain of fatigue or drowsiness. Gastrointestinal problems eg, nausea, vomiting, diarrhea and stomachache have also been reported, but their incidence during clinical trials was ≤2%. Other symptoms eg, vertigo, headaches, trembling and sexual stimulation have occasionally been reported.

Interactions:

The classical treatment for alcoholism ie, vitamins and sedatives, may continue to be prescribed during cures for alcoholism, in cases where there is a known vitamin deficiency or severe excitability. Only 1 case of interaction has been reported, where THIS MEDICINE and thyroid extract (T3 and T4) were given together and confusion, irritability and sleep disturbances were later observed.

Warnings:

Renal insufficiency (CrCl <80 mL/min), underlying haemostatic disorders, major op or severe haemorrhage. Long-term treatment in elderly, abrupt discontinuation in myoclonic patients.

Form:

TABLET

Dosage and Administration

You must sign in to use this servcie

Technical Description

You must sign in to use this servcie





Forgot your password


sign up
Consultants Corner

Dr. Hani Najjar

Dr. Hani Najjar Pediatrics, Neurology

Samir Moussa M.D.

Samir Moussa M.D. ENT Specialist

Dr. Talal Sabouni

Dr. Talal Sabouni UROLOGY AND KIDNEY TRANSPLANT

Dr. Tahsin Martini

Dr. Tahsin Martini Degree status: M.D. in Ophthalmology

Dr . Dirar Abboud

Dr . Dirar Abboud Hepatologist – Gastroenterologist

Dr. Faisal Dibsi

Dr. Faisal Dibsi Specialist of Otolaryngology - Head and Neck Surgery

Yaser Habrawi , F.R.C.S.Ed

Yaser Habrawi , F.R.C.S.Ed Consultant Ophthalmologist

Dr. Samer Al-Jneidy

Dr. Samer Al-Jneidy Pediatrician

Poll

Disclaimer : This site does not endorse or recommend any medical treatment, pharmaceuticals or brand names. More Details